Next Article in Journal
Effects of Newcastle Disease Virus Strains AF2240 and V4-UPM on Cytolysis and Apoptosis of Leukemia Cell Lines
Previous Article in Journal
Bioactive Compounds, Antioxidant, Xanthine Oxidase Inhibitory, Tyrosinase Inhibitory and Anti-Inflammatory Activities of Selected Agro-Industrial By-products
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2011, 12(12), 8626-8644; doi:10.3390/ijms12128626

Validation of Quantitative Structure-Activity Relationship (QSAR) Model for Photosensitizer Activity Prediction

1
Department of Chemistry, Faculty of Science, University of Malaya, Lembah Pantai 50603, Kuala Lumpur, Malaysia
2
Drug Design and Development Research Group, University of Malaya, Lembah Pantai 50603, Kuala Lumpur, Malaysia
3
Drug Discovery Group, Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor Darul Ehsan 47500, Malaysia
4
Department of Pharmacy, Faculty of Medicine, University of Malaya, Lembah Pantai 50603, Kuala Lumpur, Malaysia
*
Author to whom correspondence should be addressed.
Received: 19 August 2011 / Revised: 2 November 2011 / Accepted: 15 November 2011 / Published: 29 November 2011
(This article belongs to the Section Physical Chemistry, Theoretical and Computational Chemistry)

Abstract

Photodynamic therapy is a relatively new treatment method for cancer which utilizes a combination of oxygen, a photosensitizer and light to generate reactive singlet oxygen that eradicates tumors via direct cell-killing, vasculature damage and engagement of the immune system. Most of photosensitizers that are in clinical and pre-clinical assessments, or those that are already approved for clinical use, are mainly based on cyclic tetrapyrroles. In an attempt to discover new effective photosensitizers, we report the use of the quantitative structure-activity relationship (QSAR) method to develop a model that could correlate the structural features of cyclic tetrapyrrole-based compounds with their photodynamic therapy (PDT) activity. In this study, a set of 36 porphyrin derivatives was used in the model development where 24 of these compounds were in the training set and the remaining 12 compounds were in the test set. The development of the QSAR model involved the use of the multiple linear regression analysis (MLRA) method. Based on the method, r2 value, r2 (CV) value and r2 prediction value of 0.87, 0.71 and 0.70 were obtained. The QSAR model was also employed to predict the experimental compounds in an external test set. This external test set comprises 20 porphyrin-based compounds with experimental IC50 values ranging from 0.39 µM to 7.04 µM. Thus the model showed good correlative and predictive ability, with a predictive correlation coefficient (r2 prediction for external test set) of 0.52. The developed QSAR model was used to discover some compounds as new lead photosensitizers from this external test set. View Full-Text
Keywords: QSAR; photodynamic therapy; photosensitizer; porphyrin; IC50 half maximal inhibitory concentration QSAR; photodynamic therapy; photosensitizer; porphyrin; IC50 half maximal inhibitory concentration
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Frimayanti, N.; Yam, M.L.; Lee, H.B.; Othman, R.; Zain, S.M.; Rahman, N.A. Validation of Quantitative Structure-Activity Relationship (QSAR) Model for Photosensitizer Activity Prediction. Int. J. Mol. Sci. 2011, 12, 8626-8644.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top